Q&A with Robert Guenther, head of corporate venturing, Henkel Tech Ventures
Month: December 2020
Apexmic applies itself to $489m round
Ninestar’s chipmaker subsidiary, Apex Microelectronics, raised the cash from investors including Gree Electric’s Zhuhai Gree Financial Investment Management.
Boehringer Ingelheim embraces NBE for acquisition
Novo is set to exit the cancer drug developer in a purchase by another of its shareholders, Boehringer Ingelheim, that could reach $1.43bn.
Checkout.com launches fintech investment arm
The digital payment technology provider has become the latest corporate to launch a venture capital investment vehicle focused on the fintech sector.
Tencent helps produce $153m for Yonghui Fresh Food
Tencent co-led a round for supermarket chain Yonghui Superstores’ fresh food distribution spinoff with a China International Capital Corporation fund.
Baidu buys into Weimai through $100m round
The medical services app developer welcomed Baidu Capital aboard in a series C-plus round that represents its second nine-figure round.
Thoma Bravo takes majority of Venafi
Intel Capital scored an exit as private equity firm Thoma Bravo bought a majority share of the machine cybersecurity technology producer, valuing it at $1.15bn.
Societe Generale resolves Reezocar acquisition
Used vehicle purchase facilitator Reezocar has been bought by Societe Generale two years after the financial services firm supplied it with funding.
Roblox locks up Loom.ai acquisition
The realistic avatar technology developer has been picked by Roblox in a deal allowing Samsung, Gree and Dentsu to exit.
GoFor completes series A delivery
Cemex-backed last-mile delivery service GoFor has closed a $15.7m round that will support its growth in the United States.
Indico undertakes $22m series B
Nationwide Ventures contributed to a round that increased the automation software provider’s overall funding to $36m.
Samsung lifts German Bionic to $20m series A
Samsung’s Catalyst helped the industrial exoskeleton provider close a series A round that will go to advancing the company’s international expansion.
Remilk raises corporate-backed funding
Hochland, Tnuva and Tempo all contributed to an $11.3m round that will help the vegan dairy protein developer bolster its production and distribution.
Faze Medicines fades in with $81m
Eli Lilly, Novartis Venture Fund and AbbVie Ventures are among the contributors to a series A round disclosed as the neurodegenerative disorder drug developer emerged from stealth.